‘Totality of Evidence’ Approach in the Development of GP2017, an Approved Adalimumab Biosimilar
Article in Advances in Therapy (March 2024)
The most recent citing publications are shown below. View all 55 publications that cite this research output on Dimensions.
Article in Advances in Therapy (March 2024)
Article in Current Gastroenterology Reports (January 2024)
Article in Advances in Therapy (December 2023)